Fibrillin 1

From WikiMD's WELLNESSPEDIA

(Redirected from Fibrillin-1)

Protein encoded by the FBN1 gene

Fibrillin-1 is a glycoprotein that is essential for the formation of elastic fibers found in connective tissue. It is encoded by the FBN1 gene in humans. Fibrillin-1 is a major component of the extracellular matrix and plays a critical role in maintaining the structural integrity and function of various tissues.

Structure[edit]

Fibrillin-1 is a large glycoprotein with a molecular weight of approximately 350 kDa. It is composed of multiple epidermal growth factor-like (EGF-like) domains, which are interspersed with transforming growth factor beta (TGF-β) binding protein-like domains. These domains are crucial for the protein's ability to interact with other components of the extracellular matrix and to bind calcium, which is necessary for its structural stability.

Function[edit]

Fibrillin-1 is a key structural component of microfibrils, which are 10-12 nm diameter fibrils that provide a scaffold for the deposition of elastin in elastic fibers. These fibers are essential for the elasticity and resilience of tissues such as the skin, lungs, and blood vessels. Fibrillin-1 also plays a role in regulating the bioavailability of TGF-β, a cytokine involved in cell growth and differentiation.

Genetics[edit]

The FBN1 gene is located on chromosome 15 (15q21.1) and consists of 65 exons. Mutations in this gene can lead to a variety of connective tissue disorders, most notably Marfan syndrome. These mutations can result in the production of abnormal fibrillin-1 protein, which disrupts the formation and function of microfibrils.

Clinical significance[edit]

Mutations in the FBN1 gene are associated with several disorders:

Research and developments[edit]

Research into fibrillin-1 continues to provide insights into the pathogenesis of connective tissue disorders and potential therapeutic approaches. Understanding the molecular mechanisms by which fibrillin-1 mutations lead to disease can inform the development of targeted treatments.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss blog | Philadelphia weight loss blog | Sleep medicine and sleep apnea services | W8MD MedSpa and wellness | Weight loss prescriptions

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.